Letter: Post-partum rubella vaccination, anti-D immunoglobulin, and blood transfusion

Grillner, L; Forssman, L
October 1974
British Medical Journal;10/5/1974, Vol. 4 Issue 5935, p47
Academic Journal
No abstract available.


Related Articles

  • Failure of rubella immunisation after blood transfusion: birth of congenitally infected infant. Watt, R.W.; McGucken, R.B. // British Medical Journal;10/11/1980, Vol. 281 Issue 6246, p977 

    Reports the dangers of maternal rubella early pregnancy. List of vaccines against rubella; Reinfection rates of each vaccine; Effectivity of rubella immunization administered after blood transfusion.

  • Evaluation of an institution-based protocol for postpartum rubella vaccination. Eason, Erica; Naus, Monika; Sciberras, Jill; Oppenheimer, Lawrence // CMAJ: Canadian Medical Association Journal;11/13/2001, Vol. 165 Issue 10, p1321 

    Presents an evaluation of institution based policies for postpartum MMR (measles, mumps, and rubella) vaccination in Canada. Incidence of congenital rubella syndrome; Methods; Results; Implications.

  • Annex 4: Biological substances: International Standards and Reference Reagents.  // WHO Technical Report Series;2005, Issue 932, p136 

    A list of the International Standards and Reference Reagents for biological substances is presented. Some of the antigens and related substances are oral Poliomyelitis vaccine, Pertussis serotype 2, and Pertussis serotype 3. Some of the blood products and related substances are anti-D blood...

  • Prevention of haemolytic diseases of the newborn due to anti-D.  // British Medical Journal (Clinical Research Edition);2/28/1981, Vol. 282 Issue 6265, p676 

    Details ways of preventing hemolytic diseases of the newborn due to anti-D sensitization. Impact of the introduction of exchange transfusion; Availability of anti-D immunoglobulin; Advantages of antenatal treatment.

  • Measles outbreaks, postexposure prophylaxis, and treatment.  // Journal of Family Practice;Jan2005 Supplement, Vol. 54, pS20 

    This article presents a recommended schedule for the administration of mumps, measles, and rubella vaccines or measles vaccines. The patients involved are unvaccinated persons 12 months or older and those who receive antibody or blood products. A suggestion is also given on the use of...

  • Following up on unfinished business--prenatal rubella screening and postpartum vaccination. Tam, Theresa W.S. // CMAJ: Canadian Medical Association Journal;11/03/98, Vol. 159 Issue 9, p1117 

    Editorial. Presents thoughts on Canada's rubella vaccination program as of November 1998. Statistics on rubella epidemics; Reports compiled by the Canadian Pediatric Surveillance Program; The need to improve the rate of prenatal rubella screening; The convenience of performing postpartum...

  • Lobbying over the safety of MMR vaccine? Donegan, Jayne // Pulse;10/18/2004, Vol. 64 Issue 41, p24 

    Presents a letter to the editor on the safety of measles, mumps and rubella vaccine.

  • 'Charlatan' amazed at MMR intolerance. Debenham, Michael // Pulse;1/26/2004, Vol. 64 Issue 4, p23 

    Presents a letter to the editor about issues surrounding the vaccination for measles, mumps, and rubella.

  • Deteriorating trust to blame for public's MMR scepticism. Manton, Rod // Pulse;4/5/2004, Vol. 64 Issue 14, p26 

    Presents a letter concerning the skepticism of the public on measles, mumps and rubella vaccine.

  • MR/MMR Vaccine in Measles Control: A Case of Missed Opportunity? Sharma, Karun D.; Rana, Manish K. // Indian Journal of Community Medicine;Jan-Mar2014, Vol. 39 Issue 1, p49 

    A letter to the editor is presented about measles/rubella and measles, mumps and rubella vaccines.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics